These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20339136)

  • 21. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 22. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 24. Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene.
    Vairaktaris E; Vassiliou S; Avgoustidis D; Stathopoulos P; Toyoshima T; Yapijakis C
    J Oral Maxillofac Surg; 2009 Sep; 67(9):2009-12. PubMed ID: 19686941
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bisphosphonates in the treatment and prevention of bone metastases].
    Hoekman K; van Holten-Verzantvoort AT; Pinedo HM
    Ned Tijdschr Geneeskd; 1997 Nov; 141(46):2217-22. PubMed ID: 9550782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soy and breast cancer: the controversy continues.
    Martínez ME; Thomson CA; Smith-Warner SA
    J Natl Cancer Inst; 2006 Apr; 98(7):430-1. PubMed ID: 16595771
    [No Abstract]   [Full Text] [Related]  

  • 28. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sore mandible. Bisphosphonate-associated osteonecrosis.
    Damm DD; Fantasia JE
    Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M; Lawson W; Montazem A
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials.
    Kyrgidis A
    Breast Cancer Res Treat; 2010 Jan; 119(1):253-4. PubMed ID: 19585235
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.
    Dunstan CR; Felsenberg D; Seibel MJ
    Nat Clin Pract Oncol; 2007 Jan; 4(1):42-55. PubMed ID: 17183355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteonecrosis of the jaw in a patient receiving bisphosphonate therapy.
    Reilly MM
    Oncol Nurs Forum; 2007 Mar; 34(2):301-5. PubMed ID: 17573291
    [No Abstract]   [Full Text] [Related]  

  • 36. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY; Geist JR; Aksu M
    J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
    [No Abstract]   [Full Text] [Related]  

  • 37. Independent assessment supports a role for tamoxifen in breast cancer risk reduction.
    Oncology (Williston Park); 1999 Sep; 13(9):1211. PubMed ID: 10509317
    [No Abstract]   [Full Text] [Related]  

  • 38. [Breast cancer with osteoblastic bone metastasis treated successfully with bisphosphonate: a case report].
    Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1651-5. PubMed ID: 10553426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer.
    Altundag K; Altundag O; Gunduz M
    Breast Cancer Res Treat; 2005 Jan; 89(2):213. PubMed ID: 15692765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.